Innovita Biological Technology Co. Ltd. A (688253) — Net Asset Quality Index
Innovita Biological Technology Co. Ltd. A (688253) has a Net Asset Quality Index of 93.9% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.23 Billion minus total liabilities of CN¥136.00 Million yields net assets of CN¥2.10 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 688253 financial resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Innovita Biological Technology Co. Ltd. A Net Asset Quality Index Over Time (2020–2025)
This chart shows how Innovita Biological Technology Co. Ltd. A's Net Asset Quality Index has evolved across 6 annual periods from 2020 to 2025. As of March 2026, the index stands at 93.9%, representing net assets of CN¥2.10 Billion against total assets of CN¥2.23 Billion CNY. See Innovita Biological Technology Co. Ltd. short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Innovita Biological Technology Co. Ltd. A (2020–2025)
The table below presents the year-by-year Net Asset Quality Index for Innovita Biological Technology Co. Ltd. A from 2020 to 2025, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market cap of Innovita Biological Technology Co. Ltd. .
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 90.2% | CN¥2.05 Billion | CN¥2.28 Billion | CN¥223.32 Million | ▲ +0.1 pp |
| 2024 | 90.1% | CN¥1.99 Billion | CN¥2.21 Billion | CN¥219.07 Million | ▲ +0.9 pp |
| 2023 | 89.2% | CN¥1.84 Billion | CN¥2.07 Billion | CN¥223.65 Million | ▲ +2.2 pp |
| 2022 | 87.0% | CN¥1.69 Billion | CN¥1.94 Billion | CN¥253.24 Million | ▼ -5.6 pp |
| 2021 | 92.5% | CN¥738.17 Million | CN¥797.87 Million | CN¥59.70 Million | ▲ +7.1 pp |
| 2020 | 85.4% | CN¥668.01 Million | CN¥782.09 Million | CN¥114.08 Million | — |